-transparent.png){kind=logo}
Recombinant Escherichia coli-derived human interferon-gamma (rIFN-gamma) was given to a total of 20 patients by iv bolus injection at various doses once a week for 4 weeks. The sera obtained 7-10 days after the final injection were analyzed for antibodies against both rIFN-gamma and natural human IFN-gamma. Biological assays demonstrated that the postinoculation sera of the patients did not neutralize the antiviral activities of either rIFN-gamma or natural human IFN-gamma. Enzyme-linked immunosorbent assay showed that no detectable antibodies against rIFN-gamma were elicited. These results indicate that this rIFN-gamma preparation is not a potent antigen and may be suitable for longer-term clinical trials and applications in the future.
C M Liang, and
S Herren, and
M Fountoulakis, and
B Otto, and
M Hirschi, and
E Gutzwiller, and
L Gerlis
December 1987,
Journal of biological response modifiers,
C M Liang, and
S Herren, and
M Fountoulakis, and
B Otto, and
M Hirschi, and
E Gutzwiller, and
L Gerlis
August 1987,
Biochemistry,
C M Liang, and
S Herren, and
M Fountoulakis, and
B Otto, and
M Hirschi, and
E Gutzwiller, and
L Gerlis
March 1984,
Journal of immunology (Baltimore, Md. : 1950),
C M Liang, and
S Herren, and
M Fountoulakis, and
B Otto, and
M Hirschi, and
E Gutzwiller, and
L Gerlis
February 2004,
Journal of industrial microbiology & biotechnology,
C M Liang, and
S Herren, and
M Fountoulakis, and
B Otto, and
M Hirschi, and
E Gutzwiller, and
L Gerlis
July 1986,
Scandinavian journal of immunology,
C M Liang, and
S Herren, and
M Fountoulakis, and
B Otto, and
M Hirschi, and
E Gutzwiller, and
L Gerlis
July 2010,
Comparative immunology, microbiology and infectious diseases,
C M Liang, and
S Herren, and
M Fountoulakis, and
B Otto, and
M Hirschi, and
E Gutzwiller, and
L Gerlis
December 2003,
Biotechnology letters,
C M Liang, and
S Herren, and
M Fountoulakis, and
B Otto, and
M Hirschi, and
E Gutzwiller, and
L Gerlis
February 2005,
Biotechnology and applied biochemistry,
C M Liang, and
S Herren, and
M Fountoulakis, and
B Otto, and
M Hirschi, and
E Gutzwiller, and
L Gerlis
July 2014,
Biotechnology letters,
C M Liang, and
S Herren, and
M Fountoulakis, and
B Otto, and
M Hirschi, and
E Gutzwiller, and
L Gerlis
April 1993,
Journal of interferon research,
